(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.19%.
Coya Therapeutics's earnings in 2026 is -$21,669,623.On average, 9 Wall Street analysts forecast COYA's earnings for 2026 to be -$30,901,024, with the lowest COYA earnings forecast at -$32,643,943, and the highest COYA earnings forecast at -$26,847,508. On average, 8 Wall Street analysts forecast COYA's earnings for 2027 to be -$34,375,132, with the lowest COYA earnings forecast at -$48,736,027, and the highest COYA earnings forecast at -$15,763,675.
In 2028, COYA is forecast to generate -$108,628,607 in earnings, with the lowest earnings forecast at -$160,920,844 and the highest earnings forecast at -$51,231,942.